Failure to Launch: The Patent Thicket Delay of U.S. Biosimilars
October 9, 2019
Ted Mathias, Stacie Ropka, PhD, and Chantelle Ankerman
Law360
Axinn partners Ted Mathias, Stacie Ropka, and associate Chantelle Ankerman authored the Law360 article, "Failure to Launch: The Patent Thicket Delay of U.S. Biosimilars."
Click here to access the article. A subscription is required.